Recombinant Tissue Factor Pathway Inhibitor Reduces Lipopolysaccharide-Induced Pulmonary Vascular Injury by Inhibiting Leukocyte Activation
American Journal of Respiratory and Critical Care Medicine - United States
doi 10.1164/ajrccm.162.5.9911018
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2000
Authors
Publisher
American Thoracic Society